{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:20:28Z","timestamp":1787761228120,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Lichen planus (LP) is a relatively common chronic, mucocutaneous disease of autoimmune origin, involves oral mucosa, skin, scalp, nails, and genital mucosa. The prevalence of oral LP (OLP) varies worldwide, commonly seen in middle-aged and elderly people. It usually presents as symmetrical and bilateral or multiple lesions with burning sensation (BS) sometimes accompanied by pain. Corticosteroids and calcineurin inhibitors have shown promising results in the treatment of OLP, but its chronic course and unpredictable exacerbations\/remission continues to result in a high degree of morbidity. The study aimed to evaluate the efficacy of intralesional triamcinolone acetonide (injection TA) combined with topical application of TA orabase and Tacrolimus (TAC) ointment for symptomatic cases of OLP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      The prospective study included 52 symptomatic OLP patients to receive (0.5 ml) intralesional injection of TA once a week for the first 4 weeks followed by one injection in the 6\n                      <jats:sup>th<\/jats:sup>\n                      week along with TA mucosal paste (0.1%.) and TAC ointment (0.03%) in tapering dose till 8\n                      <jats:sup>th<\/jats:sup>\n                      week. The subjective symptoms including BS and pain were assessed on a 10 cm visual analog scale (VAS) and objective signs like size and site of the lesion were scored according to criterion scale modified by Thongprasom\n                      <jats:italic toggle=\"yes\">et al.<\/jats:italic>\n                      Differences were compared after 8 weeks treatment course and follow-up observations were performed at 20\n                      <jats:sup>th<\/jats:sup>\n                      week to record any recurrent lesion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      41 patients (78.8%) had complete remission of disease and 11 (21%) had shown partial improvement. The VAS scores for BS and pain improved significantly. Improvement was also noted with decrease in the average size of active lesions and the number of sites with treatment. The relapse was seen in 17 patients (41%) in the 20\n                      <jats:sup>th<\/jats:sup>\n                      week.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>TA combined with TAC is a valuable therapeutic option for the treatment of symptomatic OLP. Our findings suggest that patients have shown statistically significant improvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ccd.ccd_899_20","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T10:38:43Z","timestamp":1672310323000},"page":"236-241","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Clinical Evaluation of Efficacy of Triamcinolone Acetonide with Tacrolimus in the Management of Oral Lichen Planus"],"prefix":"10.4103","volume":"13","author":[{"given":"Cheshta","family":"Walia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelakshi Singh","family":"Rallan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudip","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20240901","doi-asserted-by":"crossref","first-page":"S25.e1","DOI":"10.1016\/j.tripleo.2006.11.001","article-title":"Oral lichen planus and oral lichenoid lesions: Diagnostic and therapeutic considerations","volume":"103","author":"Al-Hashimi","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R3-7-20240901","first-page":"E462","article-title":"Topic tacrolimus, alternative treatment for oral erosive lichen planus resistant to steroids: A case report","volume":"11","author":"Riano Arguelles","year":"2006","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"R4-7-20240901","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0194599812473237","article-title":"Intralesional injection versus mouth rinse of triamcinolone acetonide in oral lichen planus: A randomized controlled study","volume":"148","author":"Lee","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R5-7-20240901","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bjoms.2007.07.199","article-title":"Oral mucosal disease: Lichen planus","volume":"46","author":"Scully","year":"2008","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R6-7-20240901","first-page":"ZE10","article-title":"Medical management of oral lichen planus: A systematic review","volume":"10","author":"Suresh","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R7-7-20240901","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.2174\/138161212803307617","article-title":"Topical therapies for oral lichen planus management and their efficacy: A narrative review","volume":"18","author":"Bagan","year":"2012","journal-title":"Curr Pharm Des"},{"key":"R8-7-20240901","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.oooo.2016.02.002","article-title":"Possible alternative therapies for oral lichen planus cases refractory to steroid therapies","volume":"121","author":"Yang","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R9-7-20240901","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cyto.2007.11.004","article-title":"NF-KB-dependent cytokines in saliva and serum from patients with oral lichen planus: A study in an ethnic Chinese population","volume":"41","author":"Zhang","year":"2008","journal-title":"Cytokine"},{"key":"R10-7-20240901","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1601-0825.2009.01608.x","article-title":"FOXP3 T regulatory cells in lesions of oral lichen planus correlated with disease activity","volume":"16","author":"Tao","year":"2010","journal-title":"Oral Dis"},{"key":"R11-7-20240901","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s10266-016-0255-4","article-title":"The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: A case report","volume":"105","author":"Morita","year":"2017","journal-title":"Odontology"},{"key":"R12-7-20240901","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Bayat Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"R13-7-20240901","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1600-0714.1992.tb00974.x","article-title":"Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus","volume":"21","author":"Thongprasom","year":"1992","journal-title":"J Oral Pathol Med"},{"key":"R14-7-20240901","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clindermatol.2009.03.004","article-title":"Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: Facts and controversies","volume":"28","author":"Farhi","year":"2010","journal-title":"Clin Dermatol"},{"key":"R15-7-20240901","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/1735-3327.266095","article-title":"Comparison of therapeutic effect of mucoadhesive nano-triamcinolone gel and conventional triamcinolone gel on oral lichen planus","volume":"16","author":"Sadeghian","year":"2019","journal-title":"Dent Res J (Isfahan"},{"key":"R16-7-20240901","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0030-4220(90)90112-6","article-title":"Oral lichen planus: The clinical, historical, and therapeutic features of 100 cases","volume":"70","author":"Vincent","year":"1990","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"R17-7-20240901","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1601-0825.1999.tb00063.x","article-title":"Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: A placebo-controlled and comparative study between clobetasol and fluocinonide","volume":"5","author":"Carbone","year":"1999","journal-title":"Oral Dis"},{"key":"R18-7-20240901","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/0975-962X.151692","article-title":"Relative efficacy of pimecrolimus cream and triamcinolone acetonide paste in the treatment of symptomatic oral lichen planus","volume":"6","author":"Arunkumar","year":"2015","journal-title":"Indian J Dent"},{"key":"R19-7-20240901","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2340\/00015555-0070","article-title":"A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment","volume":"86","author":"Laeijendecker","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"R20-7-20240901","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2007.11.022","article-title":"Betamethasone oral mini-pulse therapy compared with topical triamcinolone acetonide (0.1%) paste in oral lichen planus: A randomized comparative study","volume":"58","author":"Malhotra","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R21-7-20240901","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-0714.2006.00441.x","article-title":"Short-term clinical evaluation of intralesional triamcinolone acetonide injection for ulcerative oral lichen planus","volume":"35","author":"Xia","year":"2006","journal-title":"J Oral Pathol Med"},{"key":"R22-7-20240901","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1600-0714.2009.00796.x","article-title":"The efficacy of topical intralesional BCG-PSN injection in the treatment of erosive oral lichen planus: A randomized controlled trial","volume":"38","author":"Xiong","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"R23-7-20240901","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2009.03.012","article-title":"Calcineurin inhibitors in oral medicine","volume":"61","author":"Al Johani","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R24-7-20240901","first-page":"917","article-title":"Oral lichen planus treated with tacrolimus 0.1%","volume":"6","author":"Resende","year":"2013","journal-title":"Int J Clin Exp Med"},{"key":"R25-7-20240901","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/jdv.12758","article-title":"Efficacy of topical tacrolimus for oral lichen planus: Real-life experience in a retrospective cohort of patients with a review of the literature","volume":"29","author":"Ribero","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R26-7-20240901","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.sdentj.2012.05.002","article-title":"Treatment of symptomatic oral lichen planus (OLP) with 0.1% tacrolimus powder in Oraguard-B-A pilot prospective study","volume":"24","author":"Malik","year":"2012","journal-title":"Saudi Dent J"},{"key":"R27-7-20240901","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1365-2133.1999.02672.x","article-title":"Erosive mucosal lichen planus: Response to topical treatment with tacrolimus","volume":"140","author":"Vente","year":"1999","journal-title":"Br J Dermatol"}],"container-title":["Contemporary Clinical Dentistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ccd.ccd_899_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:27:09Z","timestamp":1787758029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ccd.ccd_899_20"}},"subtitle":["A Pilot Prospective Observational Study"],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ccd.ccd_899_20","relation":{},"ISSN":["0976-237X"],"issn-type":[{"value":"0976-237X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}